HMOX1 and hepatocellular carcinoma: Additionally, HO-1 and NRF2 levels were significantly altered following ATO treatment, and since both proteins exhibit dual roles in cancer progression, it is crucial to thoroughly investigate their context-dependent functions in HCC treatment.